Lataa...
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
An increasing prostate-specific antigen (PSA) level during radium therapy for metastatic castrate-resistant prostate cancer (mCRPC) is not an uncommon phenomenon, especially in heavily pretreated patients; however, an increasing PSA level does not always indicate progressive disease. Bone scan, ches...
Tallennettuna:
| Julkaisussa: | Clin Genitourin Cancer |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849387/ https://ncbi.nlm.nih.gov/pubmed/27053499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.03.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|